Nigeria is expanding financial support for cancer treatment as health authorities intensify calls for early detection of breast cancer, one of the leading causes of cancer related deaths among women in the country.
The National Health Insurance Authority has urged women to take breast health seriously, undergo appropriate screening where available and seek medical attention quickly when unusual changes are detected.
Nigeria records an estimated 32,278 new breast cancer cases and 16,332 deaths annually, based on figures cited by federal health authorities and cancer stakeholders from the Global Cancer Observatory.
The figures underline a major challenge facing the country, where delayed diagnosis and the high cost of treatment can significantly reduce patients’ chances of successful care.
Beyond improving awareness, the NHIA is attempting to address one of the most difficult aspects of cancer treatment in Nigeria: affordability.
Through an expanded arrangement with pharmaceutical company Roche, eligible insured patients can receive selected cancer medicines under a cost sharing system that substantially reduces the amount paid directly by the patient.
Roche covers 50 per cent of the cost of selected medicines, while the NHIA contributes 30 per cent. The patient is responsible for the remaining 20 per cent.
The arrangement effectively removes 80 per cent of the cost of the covered medicines from the patient’s immediate financial burden.
The NHIA has also introduced additional support for radiotherapy, ranging from assistance of up to ₦400,000 to complete coverage for some eligible patients.
Other benefits available under applicable packages include mammography, CT scans, MRI scans, bone scans, laboratory investigations and other components of cancer diagnosis and treatment.
Depending on eligibility, patients may also receive support for screening, surgery, chemotherapy and continuing care.
Director General of the NHIA, Dr Kelechi Ohiri, believes the effectiveness of health insurance should ultimately be judged by whether it protects families when they face serious and expensive illnesses rather than simply by the number of people registered.
More than 23 million Nigerians are currently enrolled in the national health insurance system.
The Federal Government is also implementing the Nigeria National Cancer Control Plan 2026 to 2030, covering prevention, early diagnosis, treatment, research, survivorship, patient support, data management and development of the oncology workforce.
Six Oncology Centers of Excellence are being upgraded across the country.
Federal health authorities say facilities at University College Hospital, Ibadan, University of Benin Teaching Hospital, University of Nigeria Teaching Hospital, Enugu, and Ahmadu Bello University Teaching Hospital, Zaria, are already operational with specialized equipment.
The Cancer Access Partnership programme is also providing 27 cancer medicines in 48 formulations across 14 federal tertiary hospitals, while the Cancer Health Fund supports indigent patients battling breast, cervical and prostate cancers.
Despite these interventions, significant gaps remain.
Cancer treatment can require repeated diagnostic investigations, surgery, chemotherapy, radiotherapy and specialized medicines over extended periods, placing enormous financial pressure on households.
Health authorities are therefore stressing that Nigeria’s response must combine prevention, early detection, effective treatment and financial protection.
For thousands of women, detecting breast cancer earlier could make a significant difference not only to the cost of treatment but also to the chances of survival.
